Bo Wu Selected Research

Hydrogen Sulfide (Sulfide, Hydrogen)

5/2021	New possible silver lining for pancreatic cancer therapy: Hydrogen sulfide and its donors.
1/2020	Hydrogen sulfide and its donors: Novel antitumor and antimetastatic therapies for triple-negative breast cancer.
1/2015	Interaction of Hydrogen Sulfide with Oxygen Sensing under Hypoxia.
12/2012	Hydrogen sulfide inhibits the translational expression of hypoxia-inducible factor-1α.
12/2011	Hydrogen sulfide mediates the anti-survival effect of sulforaphane on human prostate cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bo Wu Research Topics

Disease

151	Neoplasms (Cancer) 01/2024 - 08/2003
40	Ischemic Stroke 06/2023 - 06/2007
36	Inflammation (Inflammations) 02/2024 - 08/2009
30	Stroke (Strokes) 01/2024 - 04/2008
27	Infections 02/2024 - 03/2007
23	Neoplasm Metastasis (Metastasis) 01/2024 - 02/2004
18	Alzheimer Disease (Alzheimer's Disease) 01/2024 - 12/2002
15	Cognitive Dysfunction 04/2024 - 04/2011
14	Hypoxia (Hypoxemia) 10/2023 - 12/2012
13	Breast Neoplasms (Breast Cancer) 01/2024 - 09/2006
11	Ganglion Cysts (Ganglion) 01/2024 - 01/2022
11	Pancreatic Neoplasms (Pancreatic Cancer) 01/2024 - 01/2013
11	Cerebral Hemorrhage 03/2022 - 05/2014
11	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 06/2019 - 09/2008
10	Parkinson Disease (Parkinson's Disease) 01/2024 - 07/2008
10	Renal Cell Carcinoma (Grawitz Tumor) 01/2024 - 03/2010
10	Fibrosis (Cirrhosis) 12/2023 - 01/2016
10	Prostatic Neoplasms (Prostate Cancer) 03/2023 - 12/2011
10	Body Weight (Weight, Body) 01/2023 - 09/2010
9	Ischemia 04/2024 - 02/2003
9	Hypothyroidism 01/2024 - 01/2015
9	Wounds and Injuries (Trauma) 11/2023 - 01/2015
9	Insulin Resistance 06/2023 - 09/2010
9	Colorectal Neoplasms (Colorectal Cancer) 03/2023 - 01/2015
9	Glioma (Gliomas) 01/2023 - 09/2004
9	Lung Neoplasms (Lung Cancer) 01/2023 - 11/2012
9	Carcinoma (Carcinomatosis) 01/2022 - 02/2004
9	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 02/2013
8	Stomach Neoplasms (Stomach Cancer) 04/2024 - 03/2012
8	Neuroinflammatory Diseases 01/2024 - 06/2020
8	COVID-19 11/2023 - 06/2020
8	Obesity 01/2023 - 09/2010
8	Hypertension (High Blood Pressure) 01/2023 - 04/2011
8	Hemorrhage 12/2022 - 01/2011
7	Dementia (Dementias) 04/2024 - 03/2011
7	Cardiovascular Diseases (Cardiovascular Disease) 02/2024 - 01/2014
7	Papillary Thyroid Cancer 12/2023 - 06/2012
7	Pain (Aches) 03/2023 - 05/2013
7	Carcinogenesis 01/2023 - 06/2014
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2024 - 01/2017
6	Myocardial Infarction 01/2024 - 06/2013
6	Colitis 01/2024 - 01/2015
6	Pneumonia (Pneumonitis) 11/2023 - 11/2019
6	Nasopharyngeal Carcinoma 01/2022 - 08/2006
6	Diabetes Mellitus 01/2022 - 05/2014
6	Thyroid Neoplasms (Thyroid Cancer) 03/2021 - 10/2010
5	Adenocarcinoma 04/2024 - 02/2004

Drug/Important Bio-Agent (IBA)

61	Proteins (Proteins, Gene)FDA Link 03/2024 - 09/2009
30	Biomarkers (Surrogate Marker)IBA 03/2024 - 01/2010
23	Retinaldehyde (Retinal)IBA 04/2024 - 03/2010
18	Therapeutic UsesIBA 03/2023 - 09/2004
17	LipidsIBA 01/2023 - 04/2008
17	Messenger RNA (mRNA)IBA 01/2023 - 03/2007
16	CytokinesIBA 01/2023 - 12/2008
15	MicroRNAs (MicroRNA)IBA 10/2023 - 02/2013
13	Glucose (Dextrose)FDA LinkGeneric 01/2024 - 08/2007
11	EnzymesIBA 06/2023 - 02/2007
11	Triglycerides (Triacylglycerol)IBA 06/2023 - 04/2008
10	Long Noncoding RNAIBA 12/2023 - 09/2019
9	Polysaccharides (Glycans)IBA 02/2024 - 01/2018
9	CholesterolIBA 01/2023 - 04/2008
9	Interleukin-6 (Interleukin 6)IBA 03/2022 - 12/2008
9	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2020 - 06/2007
8	Indicators and Reagents (Reagents)IBA 04/2024 - 02/2004
8	Insulin (Novolin)FDA Link 01/2023 - 09/2010
8	AntigensIBA 01/2023 - 09/2006
8	LigandsIBA 10/2022 - 09/2008
8	Cisplatin (Platino)FDA LinkGeneric 07/2022 - 09/2009
8	oxidized low density lipoproteinIBA 01/2022 - 05/2014
8	Neuroprotective AgentsIBA 06/2020 - 12/2011
7	LipopolysaccharidesIBA 01/2024 - 05/2018
7	Antiviral Agents (Antivirals)IBA 01/2024 - 01/2019
7	Peptides (Polypeptides)IBA 01/2024 - 12/2002
7	Blood Glucose (Blood Sugar)IBA 01/2024 - 09/2011
7	RNA (Ribonucleic Acid)IBA 12/2023 - 11/2018
7	C-Reactive ProteinIBA 04/2023 - 01/2019
7	Amyloid (Amyloid Fibrils)IBA 01/2022 - 02/2012
7	DNA (Deoxyribonucleic Acid)IBA 09/2021 - 08/2015
7	PolymersIBA 01/2021 - 08/2015
7	Antisense OligonucleotidesIBA 02/2020 - 09/2008
6	CateninsIBA 01/2024 - 01/2015
6	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2024 - 05/2015
6	IntegrinsIBA 01/2024 - 10/2015
6	Anti-Bacterial Agents (Antibiotics)IBA 01/2024 - 02/2014
6	Transcription Factors (Transcription Factor)IBA 11/2023 - 09/2012
6	AlbuminsIBA 10/2023 - 04/2019
6	Fibrinogen (Factor I)FDA Link 06/2023 - 04/2017
6	AntioxidantsIBA 01/2023 - 01/2019
6	Peptide Hydrolases (Proteases)FDA Link 01/2023 - 05/2004
6	salicylhydroxamic acid (SHAM)IBA 12/2022 - 09/2012
6	Hemoglobins (Hemoglobin)IBA 10/2022 - 12/2008

Therapy/Procedure

86	Therapeutics 01/2024 - 08/2006
21	Lung Transplantation 02/2023 - 08/2011
20	Drug Therapy (Chemotherapy) 10/2023 - 08/2006
9	Aftercare (After-Treatment) 04/2023 - 09/2004
9	Immunotherapy 01/2023 - 08/2010
8	Radiotherapy 01/2022 - 08/2006
7	Thrombectomy 06/2023 - 10/2019
6	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2024 - 11/2009
6	Transplantation 01/2022 - 12/2003